Special Report: You Could Lose or Make a Fortune

Sunesis Pharmaceuticals

SNSS

SNSS
Sunesis Pharmaceuticals Stock Quote
$0.29 -$0.01 -4.5%
Price as of August 4, 2020, 4:30 p.m. EDT View Interactive SNSS Charts

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.

Interactive Chart


News & Analysis: Sunesis Pharmaceuticals

All









3 Biotechs Burning Through Cash

Investors would be wise to know how biotech companies are spending that cash on hand while they develop drugs.